37 related articles for article (PubMed ID: 22169896)
1. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.
Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M
Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896
[TBL] [Abstract][Full Text] [Related]
2. TSC2/PKD1 Contiguous Gene Deletion Syndrome.
Arredondo Montero J; Bronte Anaut M; Velayos M; Sarmiento MDC; Ramírez Amorós C; López-Pereira P
Clin Pediatr (Phila); 2024 Mar; 63(3):411-413. PubMed ID: 37173860
[No Abstract] [Full Text] [Related]
3. Two novel gross deletions of TSC2 in Malaysian patients with tuberous sclerosis complex and TSC2/PKD1 contiguous deletion syndrome.
Ismail NF; Nik Abdul Malik NM; Mohseni J; Rani AM; Hayati F; Salmi AR; Narazah MY; Zabidi-Hussin ZA; Silawati AR; Keng WT; Ngu LH; Sasongko TH
Jpn J Clin Oncol; 2014 May; 44(5):506-11. PubMed ID: 24683199
[TBL] [Abstract][Full Text] [Related]
4. [TSC2/PKD1 contiguous gene deletion syndrome].
Llamas Velasco S; Camacho Salas A; Vidales Moreno C; Ceballos Rodríguez RM; Murcia García FJ; Simón de la Heras R
An Pediatr (Barc); 2013 Jul; 79(1):42-5. PubMed ID: 23402778
[TBL] [Abstract][Full Text] [Related]
5. TSC2/PKD1 contiguous gene syndrome, with emphasis on a case with an atypical mild polycystic kidney phenotype and a novel genetic variant.
Reyna-Fabián ME; Alcántara-Ortigoza MA; Hernández-Martínez NL; Berumen J; Jiménez-García R; Gómez-Garza G; González-Del Angel A
Nefrologia (Engl Ed); 2020; 40(1):91-98. PubMed ID: 31176519
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.
Brook-Carter PT; Peral B; Ward CJ; Thompson P; Hughes J; Maheshwar MM; Nellist M; Gamble V; Harris PC; Sampson JR
Nat Genet; 1994 Dec; 8(4):328-32. PubMed ID: 7894481
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
8. A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease.
Longa L; Scolari F; Brusco A; Carbonara C; Polidoro S; Valzorio B; Riegler P; Migone N; Maiorca R
Nephrol Dial Transplant; 1997 Sep; 12(9):1900-7. PubMed ID: 9306341
[TBL] [Abstract][Full Text] [Related]
9. TSC2/PKD1 contiguous gene síndrome.
Cammarata-Scalisi F; Vidales Moreno C; Zara-Chirinos C; Bracho A; Pérez D
Nefrologia; 2017; 37(6):663-665. PubMed ID: 29122219
[No Abstract] [Full Text] [Related]
10. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene.
Sampson JR; Maheshwar MM; Aspinwall R; Thompson P; Cheadle JP; Ravine D; Roy S; Haan E; Bernstein J; Harris PC
Am J Hum Genet; 1997 Oct; 61(4):843-51. PubMed ID: 9382094
[TBL] [Abstract][Full Text] [Related]
11. An overview of actionable and potentially actionable TSC1 and TSC2 germline variants in an online Database.
Garcia ABM; Viola GD; Corrêa BDS; Fischer TDS; Pinho MCF; Rodrigues GM; Ashton-Prolla P; Rosset C
Genet Mol Biol; 2024; 46(3 Suppl 1):e20230132. PubMed ID: 38373162
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants.
Demir S; Yalçıntepe S; Atlı E; Yalçın Y; İkbal Atlı E; Eker D; Karal Y; Gürkan H
Balkan Med J; 2021 Nov; 38(6):341-347. PubMed ID: 34860161
[TBL] [Abstract][Full Text] [Related]
13. Novel Roles of SH2 and SH3 Domains in Lipid Binding.
Sipeki S; Koprivanacz K; Takács T; Kurilla A; László L; Vas V; Buday L
Cells; 2021 May; 10(5):. PubMed ID: 34068055
[TBL] [Abstract][Full Text] [Related]
14. Solution NMR Structure of the SH3 Domain of Human Caskin1 Validates the Lack of a Typical Peptide Binding Groove and Supports a Role in Lipid Mediator Binding.
Tőke O; Koprivanacz K; Radnai L; Merő B; Juhász T; Liliom K; Buday L
Cells; 2021 Jan; 10(1):. PubMed ID: 33467043
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of an infant with
Osumi K; Suga K; Ono A; Goji A; Mori T; Kinoshita Y; Sugano M; Toda Y; Urushihara M; Nakagawa R; Hayabuchi Y; Imoto I; Kagami S
Hum Genome Var; 2020; 7():21. PubMed ID: 32695431
[TBL] [Abstract][Full Text] [Related]
16. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.
Cnossen WR; Maurits JS; Salomon J; Te Morsche RH; Waanders E; Drenth JP
J Clin Lab Anal; 2016 Sep; 30(5):431-6. PubMed ID: 26365003
[TBL] [Abstract][Full Text] [Related]
17. Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions.
Robert A; Leroy V; Riquet A; Gogneaux L; Boutry N; Avni FE
Radiol Med; 2016 May; 121(5):402-8. PubMed ID: 26219723
[TBL] [Abstract][Full Text] [Related]
18. Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.
Cabrera-López C; Bullich G; Martí T; Català V; Ballarín J; Bissler JJ; Harris PC; Ars E; Torra R
BMC Med Genet; 2015 Jun; 16():39. PubMed ID: 26077033
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
